These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 7437261)

  • 1. A comparative study of antipyrine and lignocaine disposition in normal subjects and in patients treated with enzyme-inducing drugs.
    Perucca E; Hedges A; Makki KA; Richens A
    Br J Clin Pharmacol; 1980 Nov; 10(5):491-7. PubMed ID: 7437261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative study of the relative enzyme inducing properties of anticonvulsant drugs in epileptic patients.
    Perucca E; Hedges A; Makki KA; Ruprah M; Wilson JF; Richens A
    Br J Clin Pharmacol; 1984 Sep; 18(3):401-10. PubMed ID: 6435654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of oral bioavailability of lignocaine by induction of first pass metabolism in epileptic patients.
    Perucca E; Richens A
    Br J Clin Pharmacol; 1979 Jul; 8(1):21-31. PubMed ID: 552293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The comparative enzyme-inducing properties of antiepileptic drugs [proceedings].
    Perucca E; Hedges A; Makki K; Hebdige S; Wadsworth J; Richens A
    Br J Clin Pharmacol; 1979 Apr; 7(4):414P-415P. PubMed ID: 444364
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacokinetics of antipyrine in epileptic patients.
    Rimmer EM; Routledge PA; Tsanaclis LM; Richens A
    Br J Clin Pharmacol; 1986 May; 21(5):511-4. PubMed ID: 3718808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The features of hepatic enzyme induction with glutethimide in man.
    Jackson L; Homeida M; Roberts CJ
    Br J Clin Pharmacol; 1978 Dec; 6(6):525-8. PubMed ID: 728322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antipyrine pharmacokinetics and D-glucaric excretion in kwashiorkor.
    Buchanan N; Eyberg C; Davis MD
    Am J Clin Nutr; 1979 Dec; 32(12):2439-42. PubMed ID: 506967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of portacaval shunt on the disposition of drugs with and without first-pass effect.
    Gugler R; Lain P; Azarnoff DL
    J Pharmacol Exp Ther; 1975 Dec; 195(3):416-23. PubMed ID: 1195128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paradoxical urinary excretion of D-glucaric acid in acute viral hepatitis.
    Sorrell MF; Burnett DA; Tuma DJ; Barak AJ
    Clin Pharmacol Ther; 1976 Sep; 20(3):365-8. PubMed ID: 954355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of low-dose phenobarbitone on three indices of hepatic microsomal enzyme induction.
    Price DE; Mehta A; Park BK; Hay A; Feely MP
    Br J Clin Pharmacol; 1986 Dec; 22(6):744-7. PubMed ID: 3567022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of urinary 6-beta-hydroxycortisol excretion as an in vivo parameter in the clinical assessment of the microsomal enzyme-inducing capacity of antipyrine, phenobarbitone and rifampicin.
    Ohnhaus EE; Park BK
    Eur J Clin Pharmacol; 1979 Mar; 15(2):139-45. PubMed ID: 35353
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacogenetic differences in the inhibitory effect of cimetidine on the metabolism of antipyrine.
    Gachályi B; Vas A; Csillag K; Nagy B; Kocsis F; Káldor A
    Eur J Clin Pharmacol; 1987; 31(5):613-5. PubMed ID: 3830247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Saliva and plasma clearance of antipyrine as reflectors of liver function.
    Luoma PV; Sotaniemi EA
    Eur J Drug Metab Pharmacokinet; 1981; 6(4):261-4. PubMed ID: 7333326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum gamma-glutamyl transpeptidase, D-glucaric acid excretion and plasma half-life of antipyrine in newborns with severe jaundice of unknown etiology and due to glucose-6-phosphate dehydrogenase deficiency in Greece.
    Malaka-Zafiriu K; Koliouskas D; Kontopoulos E; Danielides B; Cassimos C
    Helv Paediatr Acta; 1981; 36(2):149-58. PubMed ID: 6114077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of enzyme induction on diazepam metabolism in man.
    Ohnhaus EE; Park BK; Colombo JP; Heizmann P
    Br J Clin Pharmacol; 1979 Dec; 8(6):557-63. PubMed ID: 42427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antipyrine, paracetamol, and lignocaine elimination in chronic liver disease.
    Forrest JA; Finlayson ND; Adjepon-Yamoah KK; Prescott LF
    Br Med J; 1977 May; 1(6073):1384-7. PubMed ID: 861646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paracetamol disposition in normal subjects and in patients treated with antiepileptic drugs.
    Perucca E; Richens A
    Br J Clin Pharmacol; 1979 Feb; 7(2):201-6. PubMed ID: 760753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salivary antipyrine kinetics in hepatic and renal disease and in patients on anticonvulsant therapy.
    Harman AW; Penhall RK; Priestly BG; Frewin DB; Phillips PJ; Clarkson AR
    Aust N Z J Med; 1977 Aug; 7(4):385-90. PubMed ID: 270989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microsomal enzyme induction in children: the influence of carbamazepine treatment on antipyrine kinetics, 6 beta-hydroxycortisol excretion and plasma gamma-glutamyltranspeptidase activity.
    Moreland TA; Park BK; Rylance GW
    Br J Clin Pharmacol; 1982 Dec; 14(6):861-5. PubMed ID: 6129885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased clearance of antipyrine and d-propranolol after phenobarbital treatment in the monkey. Relative contributions of enzyme induction and increased hepatic blood flow.
    Branch RA; Shand DG; Wilkinson GR; Nies AS
    J Clin Invest; 1974 Apr; 53(4):1101-7. PubMed ID: 4205524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.